Table 1 |
|||
|
Clinical and demographic characteristics of patients with rheumatoid arthritis (RA) and of healthy controls |
|||
| Erosive RA (n = 88) |
Non-erosive RA (n = 43) |
Controls (n = 34) |
|
|
|
|||
| Age (years) [mean ± standard deviation (range)] |
63 ± 2 (28–85) |
53 ± 3 (19–83) |
42 ± 1.8 (18–67) |
| Sex (male/female) |
26/62 |
12/31 |
12/22 |
| Duration of the disease (years) |
12.7 ± 1.2 |
8 ± 1.4 |
- |
| Rheumatoid factor (+/-) |
80/8 |
10/33 |
n.a. |
| Treatment with DMARDs |
|||
| Methotrexate (n = 25) |
18 |
7 |
- |
| Other DMARDs (n = 13) |
9 |
4 |
|
| TNF-α blockade (n = 47) |
42 (37*) |
5 (5*) |
|
| None (n = 45) |
18 |
27 |
|
|
|
|||
|
n.a., not assesed; DMARD, disease modifying anti-rheumatic drug; TNF-α, tumour necrosis factor alpha. *In combination with methotrexate. |
|||
|
Bokarewa et al. Arthritis Res Ther 2005 7:R349 doi:10.1186/ar1498 |
|||
